Telix Pharmaceuticals Ltd.

TLX·NASDAQ·$9.57Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

20-F/AAnnual report (foreign, amended)03/20/26 20-FAnnual report (foreign)02/20/26 20-FAnnual report (foreign)02/24/25

Disclosures

6-KForeign issuer report10/29/26 6-KForeign issuer report10/21/26 6-KForeign issuer report09/30/26 6-KForeign issuer report09/21/26 6-KForeign issuer report09/14/26

Prospectuses and Registrations

F-3ASRProspectus / registration02/20/26 S-8Registration of securities for employees12/19/24 F-6Prospectus / registration10/17/24 F-1/ARegistration (foreign issuer, amended)06/05/24 F-6Prospectus / registration05/30/24

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/14/26 Form 3Initial insider ownership05/18/26 Form 3Initial insider ownership05/18/26 Form 3Initial insider ownership05/18/26 Form 4Insider transaction05/06/26

Other

UPLOADLetter from the SEC04/23/26 CORRESPCorrespondence with the SEC04/17/26 UPLOADLetter from the SEC04/03/26 SEC STAFF LETTERSEC staff letter11/21/24 CERTCEO/CFO certification11/12/24